GWAS |
- Breast cancer ( 29059683 23535729)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Estimated glomerular filtration rate ( 31152163)
- Heel bone mineral density ( 30598549)
- Metabolite levels ( 23823483)
- Migraine ( 22683712 27322543)
- Migraine - clinic-based ( 23793025)
- Night sleep phenotypes ( 27126917)
- Postprandial triglyceride response ( 32603185)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820)
- Systolic blood pressure ( 30224653)
- Tonometry ( 17903302)
|
- Alzheimer's disease ( 19734902 19734903 21627779 31473137)
- Alzheimer's disease (late onset) ( 21460841 30617256 24162737 28714976)
- Alzheimer's disease in APOE e4+ carriers ( 25778476)
- Alzheimer's disease in APOE e4- carriers ( 25778476)
- Alzheimer's disease or family history of Alzheimer's disease ( 30617256)
- Alzheimer's disease or fasting insulin levels (pleiotropy) ( 30805717)
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Family history of Alzheimer's disease ( 30617256)
- Lung adenocarcinoma ( 28604730)
- Lung cancer in ever smokers ( 28604730)
- Panic disorder ( 19165232)
- Refractive error ( 32231278)
- Schizophrenia ( 25056061 29483656)
- Smoking behaviour (cigarettes smoked per day) ( 31089300)
- Smoking status (ever vs never smokers) ( 30643258)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
|